More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...

Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

Despite today’s technological advancements, a large amount of prior authorization requests are submitted via fax machine. A new partnership between Blue Shield of California and Salesforce will ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...

Amyotrophic lateral sclerosis has been a tough area for drug research, but Eli Lilly has been spreading its bets in this neurodegenerative disease by striking deals with other companies. The ...

At the HLTH conference in Las Vegas, MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed executives who offered their insights on the shifting healthcare landscape.

Northwell Holdings — the venture capital arm of Northwell Health, the largest health system in New York state — says it is focused on making investments in innovative companies that improve patient ...